Organon & Co Stock - Thursday chart snapshot and technical picture
Published on 06/18/2026 at 19:12 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 17:05 UTC. Details in the imprint.
Organon & Co (US68622V1061) is trading without a fresh corporate headline on Thursday, so the focus turns to the stock’s chart setup and current valuation range. The shares continue to move near the lower end of their 12-month band on the New York Stock Exchange.
All news and key data on Organon & Co stock
Price data, fundamentals and future headlines for Organon & Co stock are bundled in the ad hoc news topic hub and on the company’s own investor-relations pages.
What recent prices show
Organon & Co shares most recently closed at about $13.43 on the NYSE, implying a market capitalization near $3.5 billion based on publicly available quote data. That puts the stock well below its levels seen shortly after the 2021 spin-off from Merck.
Data from trading portals indicate that the stock’s trailing price-earnings ratio is in the low-teens, around 14 times earnings, which is consistent with a cautious valuation for a mature pharmaceutical portfolio. Day-to-day moves have been relatively muted in recent sessions.
Thursday’s chart and technicals
On Thursday, Organon & Co shares are changing hands in a narrow range around the mid-teens, with intraday volatility modest compared with the broader Standard & Poor's 500 index. Trading volumes remain moderate, suggesting no major repositioning by investors.
From a descriptive perspective, the stock is hovering near the lower portion of its 52-week trading corridor, which highlights a subdued sentiment backdrop but also a period of consolidation after earlier declines. Technical traders are watching whether support in this area will continue to hold.
How the company makes money
Organon & Co generates most of its revenue from women’s health, biosimilars and legacy established brands, including well-known contraceptive and fertility products, as outlined in its corporate materials on the investor-relations website. The portfolio is global, with a strong footprint outside the United States.
Where the stock trades today
The shares of Organon & Co (US68622V1061) trade on the New York Stock Exchange at $13.43 as of 06/17/2026, 16:00 ET.
Organon & Co stock at a glance
- Company: Organon & Co Inc.
- ISIN: US68622V1061
- WKN: A3CSKB
- Ticker: OGN
- Venue: NYSE
- Price (as of 06/17/2026, 16:00 ET): 13.43 USD
- Market cap: 3.52 billion USD (as of 06/17/2026)
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: none of the major headline indices such as the S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
